Categories Earnings, Other Industries

Cushman & Wakefield Q3 loss narrowed on higher fee revenue

Commercial real estate services firm Cushman & Wakefield (CWK) reported a narrower loss in the third quarter helped by the increase in Fee revenue exceeding the increase in Fee-based operating expenses and a higher benefit from income taxes.

Net loss decreased to $48.7 million or $0.26 per share from $78.6 million or $0.55 per share in the previous year quarter. Adjusted earnings soared 181% to $0.45 per share.

Revenue grew 21% to $2.1 billion. Fee revenue increased 17% reflecting increases primarily in Leasing, Capital markets, and Property, facilities, and project management. Leasing Fee revenue increased 30% driven by an America’s increase of 33%, with the remainder of the Fee revenue growth primarily in EMEA.

Setback for Walmart as CEO of Flipkart quits over “personal misconduct”

Capital markets Fee revenue increased by 34% driven by America’s increase of 42%. Property, facilities and project management Fee revenue rose by 6% helped by an America’s rise of 5% with the remainder of the Fee revenue growth primarily in EMEA.

Gross contract costs, primarily in the Property, facilities and project management service line, increased $149.6 million driven by the $98.5 million impacts of the adoption of Topic 606. Foreign currency had a 3% unfavorable impact on Revenue.

Looking ahead into the full year 2018, the company now expects adjusted EBITDA in the range of $630 million to $650 million.

Shares of Cushman & Wakefield ended Tuesday’s regular session up 2.25% at $16.85 on the NYSE. The stock has fallen over 28% since its IPO listing on August 2, 2018.

 

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top